Shenzhen - Delayed Quote CNY

Sirio Pharma Co., Ltd. (300791.SZ)

23.52
-0.74
(-3.05%)
As of 11:02:10 AM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,213,774.79
4,211,063.84
3,582,022.30
2,507,261.82
2,368,947.62
Cost of Revenue
2,864,418.21
2,886,115.37
2,497,911.67
1,725,556.82
1,593,732.88
Gross Profit
1,349,356.58
1,324,948.47
1,084,110.63
781,705
775,214.74
Operating Expense
920,339.57
885,876.46
689,582.74
522,409.86
480,327.87
Operating Income
429,017.01
439,072.01
394,527.89
259,295.14
294,886.87
Net Non Operating Interest Income Expense
-80,321.77
-74,137
-56,002.16
-31,521.42
-7,687.41
Pretax Income
312,189.61
316,654.11
273,256.83
251,518.33
280,900.84
Tax Provision
27,555.76
34,636.19
32,969.03
39,232.75
49,066.35
Net Income Common Stockholders
330,672.70
325,061.75
281,038.53
212,285.58
231,834.49
Basic EPS
1.42
1.39
1.20
0.91
0.99
Diluted EPS
1.42
1.39
1.20
0.90
0.94
Basic Average Shares
233,241.19
233,588.49
234,433.21
234,012.76
234,048.95
Diluted Average Shares
233,241.19
233,588.49
234,433.21
236,337.46
247,401.77
Total Operating Income as Reported
319,021.72
327,007.29
282,024.67
265,055.98
289,814.71
Rent Expense Supplemental
--
13,441.95
14,427.38
4,198.80
7,888.25
Total Expenses
3,784,757.78
3,771,991.83
3,187,494.41
2,247,966.68
2,074,060.75
Net Income from Continuing & Discontinued Operation
330,672.70
325,061.75
281,038.53
212,285.58
231,834.49
Normalized Income
353,654.83
349,753.28
335,918.19
221,117.32
235,064.84
Interest Income
7,478.27
6,887.67
7,016.14
11,578.05
6,992.89
Interest Expense
85,324.09
78,740.40
61,856.08
41,632.23
13,434.96
Net Interest Income
-80,321.77
-74,137
-56,002.16
-31,521.42
-7,687.41
EBIT
397,513.70
395,394.51
335,112.91
293,150.56
294,335.80
EBITDA
397,513.70
634,661.89
592,070.50
424,892.37
398,397.65
Reconciled Cost of Revenue
2,864,418.21
2,886,115.37
2,497,911.67
1,725,556.82
1,593,732.88
Reconciled Depreciation
--
239,267.38
256,957.60
131,741.81
104,061.85
Net Income from Continuing Operation Net Minority Interest
330,672.70
325,061.75
281,038.53
212,285.58
231,834.49
Total Unusual Items Excluding Goodwill
-25,207.06
-27,724.04
-62,409.50
-10,463.95
-3,914.03
Total Unusual Items
-25,207.06
-27,724.04
-62,409.50
-10,463.95
-3,914.03
Normalized EBITDA
422,720.76
662,385.93
654,480
435,356.31
402,311.68
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,224.93
-3,032.50
-7,529.84
-1,632.20
-683.68
12/31/2021 - 9/25/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SB7.F Saputo Inc.
17.07
+1.07%
 
HO7.BE Hormel Foods Corp
26.60
+2.90%
 
KU9.F WK Kellogg Co
15.28
+1.46%
 
GCHE.ME Public Joint Stock Company "Cherkizovo Group"
2,650.50
+0.06%
 
RCL.JO RCL Foods Limited
984.00
+2.29%
 
0SL.F Scandi Standard AB (publ)
8.06
-0.86%
 
ITM1.SG Italmobiliare SpA
26.00
+0.78%
 
BIO.VI Biogena Group Invest AG
2.1400
+9.18%
 
VEZ.SG Veganz Group AG
12.80
-3.40%
 
SVRT.TA SavorEat Ltd.
254.60
-2.45%